Not enough evidence to justify ovarian cancer screeningBMJ 1999; 318 doi: https://doi.org/10.1136/bmj.318.7185.687 (Published 13 March 1999) Cite this as: BMJ 1999;318:687
View Full Text
- Richard Woodman
Screening women for ovarian cancer should not be considered until the potential benefit, harm, and cost have been assessed in randomised clinical trials, says a report from the NHS Centre for Reviews and Dissemination.
Dr Ruth Bell, a visiting research fellow at the centre, and her coauthors said that a systematic review of prospective screening studies showed that ultrasound screening and the serum test for CA125 could detect ovarian cancer …
Log in using your username and password
Log in through your institution
Subscribe from £173 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£38 / $45 / €42 (excludes VAT)
You can download a PDF version for your personal record.